Point72 Hong Kong’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Point72 Hong Kong’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,077	Closed	-$62K	–	2592
2021 Q3	$62K	Buy	+3,077	New	+$85K	﹤0.01%	1473
2021 Q2	–	Sell	-350	Closed	-$9K	–	2510
2021 Q1	$9K	Sell	350 -2,480	-88%	-$63.3K	﹤0.01%	1601
2020 Q4	$62K	Buy	+2,830	New	+$62.3K	﹤0.01%	1170
2019 Q1	–	Sell	-147	Closed	-$2K	–	1369
2018 Q4	$2K	Sell	147 -2,132	-94%	-$28K	﹤0.01%	765
2018 Q3	$35K	Buy	+2,279	New	+$33.2K	0.01%	520

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Point72 Hong Kong's DRNA Position: Q4 2021 in Review

Point72 Hong Kong sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 3,077 shares — an estimated $62K sold.

Point72 Hong Kong first reported a position in DRNA in Q3 2018 and held it in 5 quarters. The position peaked at $62K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Point72 Hong Kong reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Point72 Hong Kong sold 3,077 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $62K.
Point72 Hong Kong first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2018 and held it in 5 quarters.
Point72 Hong Kong's Dicerna Pharmaceuticals, Inc. position peaked at $62K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.